Drug data last refreshed 20h ago · AI intelligence enriched 1w ago
OXYGEN, USP is a pharmaceutical-grade oxygen gas product administered via inhalation for patients requiring supplemental oxygen therapy. It is an essential respiratory support agent used across acute and chronic care settings to restore adequate oxygenation in hypoxemic patients.
Peak-stage product with moderate competitive pressure (30%) indicates a mature, stable market with established distribution infrastructure and limited headroom for market growth.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Safety Study of Intravenous Hydrogen-Oxygen Ultrafine Bubbles in Adults
Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants
MolecuLight All-in-One Oxygenation Clinical Utility
Endoscopic COlorectal Mucosal Evaluation of Oxygen Tension
Impact of Intraoperative Oxygenation Practices on Patient Outcomes
Worked on OXYGEN, USP at Universal Cells? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Universal Cells is hiring 1 role related to this product
The 4 linked roles are primarily technical and operational in nature, reflecting the product's maturity and focus on manufacturing excellence, quality assurance, and supply chain stability rather than commercial expansion. Career progression on OXYGEN, USP will emphasize process optimization, regulatory compliance, and operational leadership over product launch or market development.
4 open roles linked to this drug